Recently, Tosei Biochemical's wholly-owned subsidiary Dongcheng Andi's Anhui subsidiary has completed the filing of commissioned production for fluorine [18F] deoxyglucose injection, marking the start of production for the Anhui Nuclear Medicine Production Center.
东诚药业新增安徽核药生产中心
Tosei Biochemical, Anhui Nuclear Medicine Production Center is newly added.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.